← Back to Search

Green and White LED Light Therapy for Chronic Pain

N/A

Waitlist Available

Led By Mohab Ibrahim, PhD., MD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Peripheral neuropathy from HIV or chemotherapy.

Peripheral neuropathy from HIV or chemotherapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 - 22 weeks, depending on study arm

Summary

This trial is investigating whether or not light therapy can be used as a pain management technique for chronic pain sufferers.

Who is the study for?

This trial is for adults aged 18-80 with chronic pain, such as fibromyalgia or peripheral neuropathy from HIV/chemotherapy, who have a pain score of at least 5/10. Participants must understand English and follow the study plan. It's not for those incarcerated, unable to read English, paid for their pain treatment, or with addiction issues or severe depression.

What is being tested?

The trial tests if green LED light therapy can reduce chronic pain better than white LED light (control). Participants will use their assigned LED lights in a dark room for two hours daily over three months. The study aims to see if this reduces the need for painkillers and improves life quality.

What are the potential side effects?

LED light therapy is considered safe; however, potential side effects are not detailed in this summary. Generally, light therapy may cause eye strain or headache but typically has fewer side effects compared to pharmacological treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have nerve pain or tingling from HIV or chemotherapy.

Select...

I have nerve pain or tingling from HIV or chemotherapy.

Select...

My average pain level is 5 or more out of 10.

Select...

I have been diagnosed with fibromyalgia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 - 22 weeks, depending on study arm

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 - 22 weeks, depending on study arm

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 - 22 weeks, depending on study arm for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

For fibromyalgia pain.

For migraine headache pain.

Secondary study objectives

Ability to Do Chores

Ability to Excersize

Ability to Fall Asleep

+15 more

Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Exposure to green LED lightExperimental Treatment1 Intervention

Subjects will exposed to green light provided to them, in their homes in a dark room for approximately 2 hours for 10 weeks.

Group II: Cross overExperimental Treatment2 Interventions

Subject will be exposed to white light (sham) for 10 weeks, then have a wash out period for 2 weeks, then exposed to green light (experimental) for 10 weeks.

Group III: Exposure to white LED light.Placebo Group1 Intervention

Subjects will exposed to white light provided to them, in their homes in a dark room for approximately 2 hours for 10 weeks

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exposure to green LED light

2021

N/A

~30

Exposure to white LED light

2021